Literature DB >> 26027937

Microwave Ablation Compared to Radiofrequency Ablation for Hepatic Lesions: A Meta-Analysis.

Ya Ruth Huo1, Guy D Eslick2.   

Abstract

To evaluate the efficacy and safety of microwave (MW) ablation compared with radiofrequency (RF) ablation for hepatic lesions by using meta-analytic techniques. Overall, 16 studies involving 2,062 patients were included. MW ablation was found to have significantly better 6-year overall survival than RF ablation (odds ratio, 1.64, 95% confidence interval, 1.15-2.35), but this was based on a few articles (n = 3 of 16). MW ablation and RF ablation had similar 1-5-year overall survival, disease-free survival, local recurrence rate, and adverse events. Based on similar safety and efficacy outcomes, either MW ablation or RF ablation may be used for effective local hepatic therapy. Crown
Copyright © 2015. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26027937     DOI: 10.1016/j.jvir.2015.04.004

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  30 in total

Review 1.  Thermal Ablation in the Management of Colorectal Cancer Patients with Oligometastatic Liver Disease.

Authors:  Elena Nadia Petre; Constantinos Sofocleous
Journal:  Visc Med       Date:  2017-02-03

Review 2.  Local treatment of oligometastatic disease: current role.

Authors:  Moritz T Winkelmann; Stephan Clasen; Philippe L Pereira; Rüdiger Hoffmann
Journal:  Br J Radiol       Date:  2019-06-06       Impact factor: 3.039

3.  Percutaneous ablation of post-surgical solitary early recurrence of colorectal liver metastases is an effective "test-of-time" approach.

Authors:  Luca Vigano; Jacopo Galvanin; Dario Poretti; Daniele Del Fabbro; Damiano Gentile; Vittorio Pedicini; Luigi Solbiati; Guido Torzilli
Journal:  Updates Surg       Date:  2021-04-12

Review 4.  Microwave ablation in primary and secondary liver tumours: technical and clinical approaches.

Authors:  Maria Franca Meloni; Jason Chiang; Paul F Laeseke; Christoph F Dietrich; Angela Sannino; Marco Solbiati; Elisabetta Nocerino; Christopher L Brace; Fred T Lee
Journal:  Int J Hyperthermia       Date:  2016-08-02       Impact factor: 3.914

5.  Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control.

Authors:  Waleed Shady; Elena N Petre; Kinh Gian Do; Mithat Gonen; Hooman Yarmohammadi; Karen T Brown; Nancy E Kemeny; Michael D'Angelica; Peter T Kingham; Stephen B Solomon; Constantinos T Sofocleous
Journal:  J Vasc Interv Radiol       Date:  2017-12-06       Impact factor: 3.464

Review 6.  Complications from percutaneous microwave ablation of liver tumours: a pictorial review.

Authors:  Cheng Fang; Kelvin Cortis; Gibran T Yusuf; Stephen Gregory; Dylan Lewis; Pauline Kane; Praveen Peddu
Journal:  Br J Radiol       Date:  2019-05-13       Impact factor: 3.039

7.  Overview of Ablative Therapy for Hepatocellular Carcinoma.

Authors:  Steven C Rose
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-09

Review 8.  [Locoregional and local ablative treatment options for liver tumors].

Authors:  J B Hinrichs; F K Wacker
Journal:  Internist (Berl)       Date:  2020-02       Impact factor: 0.743

Review 9.  Treatment Options for Early-Stage Hepatocellular Carcinoma.

Authors:  Nora E Tabori; Gajan Sivananthan
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

Review 10.  Interventional Oncology Approach to Hepatic Metastases.

Authors:  Cathal O'Leary; Michael C Soulen; Susan Shamimi-Noori
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.